These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31831118)

  • 21. [Bilateral spontaneous fracture of the femoral neck in renal osteopathy; with a note on intestinal lavage in uremia].
    DOHRMANN R
    Chirurg; 1953 Oct; 24(10):470-2. PubMed ID: 13127126
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes to calcium-phosphate metabolism associated with chronic nephropathies].
    Blahoš J; Sotorník I
    Vnitr Lek; 2012; 58(7-8):512-8. PubMed ID: 23067156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mineral bone disorders in chronic kidney disease.
    Hou YC; Lu CL; Lu KC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
    Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
    Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
    Matsumoto T; Fukushima S; Kanasaki T; Hagino S
    Biol Trace Elem Res; 2012 Dec; 150(1-3):278-84. PubMed ID: 22700181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular remodeling during arteriovenous fistula maturation in a rodent uremia model.
    Langer S; Paulus N; Koeppel TA; Greiner A; Buhl A; Krombach GA; Jacobs MJ; Kennes L; Kokozidou M
    J Vasc Access; 2011; 12(3):215-23. PubMed ID: 21104672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vascular calcifications in chronic kidney disease].
    Marinelli A; Loi MR; Londrino F; Logias F; Fiorini F; Granata A
    G Ital Nefrol; 2012; 29 Suppl 57():S83-9. PubMed ID: 23229533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complications and treatment of mineral and bone disorders in chronic kidney disease].
    Jean G; Chazot C
    Nephrol Ther; 2019 Jul; 15(4):242-258. PubMed ID: 31133415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New Developments in CKD-MBD. Imbalance of myocardial oxygen supply and demand in CKD patients with cardiovascular calcification].
    Joki N; Hayashi T
    Clin Calcium; 2014 Dec; 24(12):1779-84. PubMed ID: 25423922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of Vascular Calcification after Reversal of Uremia.
    Lomashvili KA; Manning KE; Weitzmann MN; Nelea V; McKee MD; O'Neill WC
    Am J Pathol; 2017 Feb; 187(2):332-338. PubMed ID: 27939134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular calcification in chronic kidney disease].
    Battaglia Y; Russo L; Asimakopoulos G; Storari A
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder.
    Tanaka H; Komaba H; Koizumi M; Kakuta T; Fukagawa M
    J Ren Nutr; 2012 Jan; 22(1):98-101. PubMed ID: 22200424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.
    Khouzam N; Wesseling-Perry K
    Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of aldosterone in uremic vascular calcification in patient with end-stage renal disease].
    Yan TK; Jia JY; Lin S
    Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):383-6. PubMed ID: 21416933
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic kidney disease--mineral and bone disorder: a complex scenario.
    Mejía N; Roman-García P; Miar AB; Tavira B; Cannata-Andía JB
    Nefrologia; 2011; 31(5):514-9. PubMed ID: 21959717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Periosteal neostosis in uremic osteodystrophy].
    Bedani PL; Tamarozzi R; Scutellari PN; Orzincolo C; Farinelli A
    Minerva Nefrol; 1983; 30(3):149-56. PubMed ID: 6646489
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of bone diseases on the morphology of the joints (lunatummalacia and sacroiliacal pseudolitation in renal osteopathy)].
    Dihlmann W
    Verh Dtsch Ges Rheumatol; 1974; 3(0):164-7. PubMed ID: 4839636
    [No Abstract]   [Full Text] [Related]  

  • 40. Resorption of condyloid process of mandible. An unusual manifestation of renal osteodystrophy.
    Sellers A; Winfield AC; Massry SG
    Arch Intern Med; 1973 May; 131(5):727-8. PubMed ID: 4701384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.